相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibody Conjugates for Sarcoma Therapy: How Far along Are We?
Letizia Polito et al.
BIOMEDICINES (2021)
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S. Hong et al.
LANCET ONCOLOGY (2020)
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha et al.
FRONTIERS IN ONCOLOGY (2020)
POTENT TUMOR-DIRECTED T CELL ACTIVATION AND IN VIVO TUMOR INHIBITION INDUCED BY A 4-1BB X 5T4 ADAPTIR™ BISPECIFIC ANTIBODY
Michelle Nelson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high-grade soft-tissue sarcoma
Takuya Kakimoto et al.
ONCOLOGY LETTERS (2019)
Sarcomas in the United States: Recent trends and a call for improved staging
Michele M. Gage et al.
Oncotarget (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer
Gemma L. Owens et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Soft Tissue Sarcoma, Version 2.2018
Margaret von Mehren et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug Conjugates
Laurel M. Schunselaar et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Theodore W. Laetsch et al.
LANCET ONCOLOGY (2018)
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
Patrick Schoffski et al.
LANCET RESPIRATORY MEDICINE (2018)
Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers
Nicolas Penel et al.
CANCER (2018)
Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma
Jia-Lin Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors
Geoffrey I. Shapiro et al.
INVESTIGATIONAL NEW DRUGS (2017)
The Solid Mechanics of Cancer and Strategies for Improved Therapy
Triantafyllos Stylianopoulos
JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME (2017)
Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients
Steven R. Pirie-Shepherd et al.
PLOS ONE (2017)
Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma
Yoshinori Imura et al.
CANCER SCIENCE (2016)
Phenotype of TPBG Gene Replacement in the Mouse and Impact on the Pharmacokinetics of an Antibody-Drug Conjugate
George Hu et al.
MOLECULAR PHARMACEUTICS (2015)
Understanding and exploiting 5T4 oncofoetal glycoprotein expression
Peter L. Stern et al.
SEMINARS IN CANCER BIOLOGY (2014)
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
C. A. Stiller et al.
EUROPEAN JOURNAL OF CANCER (2013)
Perfusion CT: A biomarker for soft tissue tumors of extremities
Merit Mohamed ElMaadawy et al.
EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE (2013)
Delineation of a Cellular Hierarchy in Lung Cancer Reveals an Oncofetal Antigen Expressed on Tumor-Initiating Cells
Marc Damelin et al.
CANCER RESEARCH (2011)
Waif1/5T4 Inhibits Wnt/β-Catenin Signaling and Activates Noncanonical Wnt Pathways by Modifying LRP6 Subcellular Localization
Birgit Kagermeier-Schenk et al.
DEVELOPMENTAL CELL (2011)
Soft Tissue Sarcoma Across the Age Spectrum: A Population-Based Study From the Surveillance Epidemiology and End Results Database
Andrea Ferrari et al.
PEDIATRIC BLOOD & CANCER (2011)
Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
Robert J. Amato et al.
CLINICAL CANCER RESEARCH (2010)
Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients
Iyad Sultan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Expression of HER1/EGFR protein in human soft tissue sarcomas
J. -L. Yang et al.
EJSO (2006)
CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis
Y Oda et al.
MODERN PATHOLOGY (2006)
Immunoplacental therapy, a potential multi-epitope cancer vaccine
A Harandi
MEDICAL HYPOTHESES (2006)
Microvessel density does not predict outcome in high grade soft tissue sarcoma
CC West et al.
EJSO (2005)
Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys
P Sapra et al.
CLINICAL CANCER RESEARCH (2005)
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial
J Verweij et al.
LANCET (2004)
Impact of c-Met expression on angiogenesis in soft tissue sarcomas:: correlation to microvessel-density
C Kuhnen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen
G Forsberg et al.
BRITISH JOURNAL OF CANCER (2001)
Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors
V Wallenius et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
